0001104659-21-128645.txt : 20211021
0001104659-21-128645.hdr.sgml : 20211021
20211021205057
ACCESSION NUMBER: 0001104659-21-128645
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211021
FILED AS OF DATE: 20211021
DATE AS OF CHANGE: 20211021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Merck KGaA
CENTRAL INDEX KEY: 0001764133
STATE OF INCORPORATION: 2M
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 211338457
BUSINESS ADDRESS:
STREET 1: FRANKFURTER STR. 250
CITY: DARMSTADT
STATE: 2M
ZIP: 64293
BUSINESS PHONE: 004961517245950
MAIL ADDRESS:
STREET 1: FRANKFURTER STR. 250
CITY: DARMSTADT
STATE: 2M
ZIP: 64293
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
tm2130646-14_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2021-10-21
0
0001840233
Xilio Therapeutics, Inc.
XLO
0001764133
Merck KGaA
FRANKFURTER STRASSE 250
DARMSTADT
2M
64293
GERMANY
0
0
1
0
Series B Preferred Stock
Common Stock
416060
I
See footnote
Series C Preferred Stock
Common Stock
264765
I
See footnote
The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
The shares are held directly by Merck Ventures B.V. Merck Ventures B.V. is a wholly owned indirect subsidiary of Merck KGaA, a publicly traded company. Merck KGaA may be deemed to have sole voting and dispositive power with respect to the shares held by Merck Ventures B.V.
The Series C Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
/s/ Christian Uhrich, Authorized signatory of Merck KGaA, Darnstadt, Germany
2021-10-21
/s/ Dr. Melanie Eckhardt, Authorized signatory of Merck KGaA, Darnstadt, Germany
2021-10-21